Net Income

Despite revenue growth, ICAPE Group posts a net loss after deciding to close two plants, signaling a pivot to a leaner model focused on innovation.

As big banks retreat, private lenders and small investors are revitalizing neighborhoods and adding homes to a market in desperate need of supply.

The company's B-cell cancer assay has achieved stringent IVDR certification, navigating a complex landscape and gaining a key edge in Europe's market.

With revenues up but losses widening, Arverne Group is aggressively investing in geothermal energy and lithium to secure France's energy independence.

The enclosure manufacturer reversed a 2024 loss, reporting a $282,000 profit for 2025 on a 30.7% revenue surge, signaling a strong market recovery.

Strong product sales and innovation clash with a steep service decline in Europe, forcing Enerpac to restructure and adjust its outlook for 2026.

The successful launch of rosacea treatment Emrosi™ generated $14.7M, driving Journey Medical's revenue to $61.9M and signaling a major strategic win.

Adhesives giant H.B. Fuller expands margins and raises its 2026 outlook, signaling operational strength amid market softness and supply chain turmoil.

The smart glasses maker reports record sales driven by niche products, yet continued investment in global expansion keeps the company in the red for now.

Armata Pharmaceuticals posts a staggering $174M annual loss, triggering a 'going concern' alert, yet its promising phage therapy pipeline advances.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.

Homebuilder Beazer Homes surpasses $10M for Fisher House, funding one million nights of lodging for veteran families through remarkable employee-led efforts.

A new high-tech wellness center arrives in Boulder, offering cutting-edge services. But does the science support the high price of proactive health?

The MEMS specialist saw revenue dip on a sharp medical decline, but booming aerospace sales, a higher margin, and a new dividend signal a strategic pivot.

Investview rebrands its controversial iGenius platform to Conectiv, adding wellness. But can a new name escape a history of regulatory fines and pyramid scheme allegations?

A federal judge's ruling allows a lawsuit to proceed over an alleged $2.2B valuation gap, placing the secretive world of corporate appraisal under a microscope.

With adjusted EPS up 20.8%, HighCo's strategic acquisitions and focus on promotion activation signal a new era of specialized growth and market leadership.

Philadelphia's Lyric earns a top innovation award by using AI to slash healthcare waste, turning a process that took months into one that takes days.

First Federal Bank boosts its lending to Ellianos Coffee, accelerating the drive-thru chain's rapid expansion in a competitive, high-growth market.

With 1.9M players and only 1 public court per 6,700 residents, USTA Florida calls for urgent investment to meet surging demand and unlock economic benefits.